Dr Camille Carroll
Profiles

Dr Camille Carroll

Associate Professor and Honorary Consultant Neurologist

Peninsula Medical School (Faculty of Health)

Role

Honorary Consultant Neurologist, Plymouth Hospitals NHS Trust

National Specialty Lead for Neurodegenerative Diseases NIHR CRN

Parkinson’s Specialty Lead and Cluster 4 Clinical Research Lead South West Peninsula CRN


Integrated Clinical Academic Training Lead


Qualifications

Dr Carroll is an academic consultant neurologist. She undertook her preclinical medical training at the University of Manchester,where she also completed an intercalated PhD (1994) investigating NMDA receptor antagonists in models of Parkinson's disease (PD). She completed her clinical training at the University of Oxford in 1997 and undertook specialist neurology training in the South West and West Midlands. In 2007 Dr Carroll was awarded a Medical Research Council fellowship which allowed her to develop research interests investigating neuroprotective mechanisms in cell culture models of Parkinson's disease. 



Roles on external bodies

Dr Carroll sits on the Grant Assessment Panel 1 for Parkinson's UK, the Research Committee for the Cure Parkinson's Trust and the Linked Clinical Trials Committee. She has previously chaired the Data Monitoring Committee for the GDNF trial in Parkinson's disease. She is regional representative on the Association of British Neurologists Research Committee. She is a member of the  Examination Board  and  Question Writing Group  for the Neurology SCE.

Research interests

Dr Carroll's current research focus is on clinical trials of neuroprotective interventions in Parkinson's disease, currently being the chief investigator of a multi-centre clinical trial of simvastatin as a potential neuroprotective therapy in PD (PD-STAT). She also has an interest in the use of technology (wearable sensors and apps) for early disease detection, personalising therapy and monitoring disease progression. She has overseen the development of a PD DNA bank (2700 samples) and a regional PD clinical research register. She was appointed National Specialty Lead for Neurodegenerative Disease in 2017. She has been PD Speciality Lead, South West Peninsula CRN since April 2014, previously being joint PD Research Director for SW DeNDRoN (2010-2014). She was Chair of the Peninsula Parkinson’s Excellence Network (PenPEN) (2015-2017).

Within University Hospitals Plymouth NHS Trust, Dr Carroll leads development of the Parkinson’s disease service, which won a Parkinson's Excellence Network Award in 2017. She also leads a successful trial delivery team, overseeing a mixed portfolio of Parkinson's clinical studies - commercial and non-commercial, interventional and observational. 

Research groups

Key publications are highlighted

Journals
Articles
Richardson SJ, Carroll C, Close J, Gordon AL, O'Brien J, Quinn TJ, Rochester L, Sayer AA, Shenkin SD & van der Velde N 2020 'Research with older people in a world with COVID-19: identification of current and future priorities, challenges and opportunities' Age and Ageing , DOI PEARL
Edwards E & Carroll C 2020 'In reply to: Helmich and Bloem (2020) “The Impact of the COVID-19 Pandemic on Parkinson’s Disease: Hidden Sorrows and Emerging Opportunities”' Journal of Parkinson's Disease 1-2 , DOI PEARL
Barker RA, Bjorklund A, Gash DM, Whone A, Van Laar A, Kordower JH, Bankiewicz K, Kieburtz K, Saarma M & Booms S 2020 'GDNF and Parkinson’s Disease: Where Next? A Summary from a Recent Workshop' Journal of Parkinson's Disease 1-17 , DOI PEARL
Zeissler M-L, Li V, Parmar MKB & Carroll CB 2020 'Is It Possible to Conduct a Multi-Arm Multi-Stage Platform Trial in Parkinson’s Disease: Lessons Learned from Other Neurodegenerative Disorders and Cancer' Journal of Parkinson's Disease 10, (2) 413-428 , DOI PEARL
Kelly J, Moyeed R, Carroll C, Luo S & Li X 2020 'Genetic networks in Parkinson’s and Alzheimer’s disease' Aging , DOI PEARL
Reichmann H, Lees A, Rocha J-F, Magalhães D & Soares-da-Silva P 2020 'Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study' Translational Neurodegeneration 9, (1) , DOI PEARL
Williams NM, Hubbard L, Sandor C, Webber C, Hendry H, Carroll C, Lawton M, Chaudhuri KR, Morris H & Hu MT 2020 'Genome-wide association study of pain in Parkinson’s disease implicates TRPM8 as a risk factor' Movement Disorders , DOI PEARL
Soundy A, Collett J, Lawrie S, Coe S, Roberts H, Hu M, Bromley S, Harling P, Reed A & Coeberg J 2019 'A qualitative study on the impact of First Steps- a peer-led, educational intervention for people newly diagnosed with Parkinson’s Disease' Behavioral Sciences , DOI PEARL
Carroll C, Webb D, Stevens ??? KN, Vickery J, Eyre V, Ball S, Wyse R, Webber M, Foggo A & Zajicek J 2019 'Simvastatin as a neuroprotective treatment for Parkinson’s disease (PD STAT): protocol for a double-blind, randomised, placebo-controlled futility study' BMJ Open , DOI PEARL
Carroll C, Kobylecki C, Silverdale M & Thomas C 2019 'Impact of Quantitative Assessment of Parkinson’s Disease-Associated Symptoms Using Wearable Technology on Treatment Decisions' Journal of Parkinson's Disease 9, (3) 601-601 , DOI PEARL
Carroll CB, Wyse RKH & Grosset DG 2019 'Statins and Parkinson's: A complex interaction' Movement Disorders 34, (7) 934-935 , DOI PEARL
Trivedi DK, Sinclair E, Xu Y, Sarkar D, Walton-Doyle C, Liscio C, Banks P, Milne J, Silverdale M & Kunath T 2019 'Discovery of Volatile Biomarkers of Parkinson’s Disease from Sebum' ACS Central Science 5, (4) 599-606 , DOI PEARL
Kelly J, Moyeed R, Carroll C, Albani D & Li X 2019 'Gene expression meta-analysis of Parkinson’s disease and its relationship with Alzheimer’s disease' Molecular Brain , DOI PEARL
Martinez-Martin P, Rizos AM, Wetmore JB, Antonini A, Odin P, Pal S, Sophia R, Carroll C, Martino D & Falup-Pecurariu C 2018 'Relationship of Nocturnal Sleep Dysfunction and Pain Subtypes in Parkinson's Disease' Movement Disorders Clinical Practice , DOI PEARL
Carroll CB, Fackrell R, Grosset D, Mohamed B, Reddy P, Parry M, Chaudhuri K & Foltynie T 2018 'Noninvasive options for ‘wearing-off’ in Parkinson's disease: a clinical consensus from a panel of UK Parkinson's disease specialists' Neurodegenerative Disease Management PEARL
Eke CS, Jammeh E, Li X, Carroll C, Pearson S & Ifeachor E 2018 'Identification of Optimum Panel of Blood-based Biomarkers for Alzheimer’s Disease Diagnosis Using Machine Learning' 2018 40th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) , DOI PEARL
Jammeh EA, Carroll CB, Pearson SW, Escudero J, Anastasiou A, Zhao P, Chenore T, Zajicek J & Ifeachor E 2018 'Machine-learning based identification of undiagnosed dementia in primary care: a feasibility study' BJGP Open bjgpopen18X101589-bjgpopen18X101589 , DOI PEARL
Ramaswamy B, Jones J & Carroll C 2018 'Exercise for people with Parkinson’s: a practical approach' Practical Neurology 18, (5) , DOI PEARL
Martinez-Martin P, Rizos AM, Wetmore J, Antonini A, Odin P, Pal S, Sophia R, Carroll C, Martino D & Falup-Pecurariu C 2018 'First comprehensive tool for screening pain in Parkinson's disease: The King's Parkinson's Disease Pain Questionnaire (KPPQ)' European Journal of Neurology 25, (10) 1255-1261 Author Site , DOI PEARL
Carroll CB & Wyse RKH 2017 'Simvastatin as a Potential Disease-Modifying Therapy for Patients with Parkinson’s Disease: Rationale for Clinical Trial, and Current Progress' Journal of Parkinson's Disease , DOI PEARL
Lubbe SJ, Escott-Price V, Brice A, Gasser T, Pittman AM, Bras J, Hardy J, Heutink P, Wood NM & Singleton AB 2016 'Rare variants analysis of cutaneous malignant melanoma genes in Parkinson's disease' Neurobiology of Aging 48, 222.e1-222.e7 , DOI PEARL
Jammeh E, Zhao P, Carroll C, Pearson S & Ifeachor E 2016 'Identification of blood biomarkers for use in point of care diagnosis tool for Alzheimer's disease' 2016 38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) , DOI PEARL
Zeissler M-L, Eastwood J, McCorry K, Hanemann OC, Zajicek JP & Carroll CB 2016 'Delta-9-tetrahydrocannabinol protects against MPP<sup>+</sup> toxicity in SH-SY5Y cells by restoring proteins involved in mitochondrial biogenesis' Oncotarget , DOI PEARL
Chaudhuri KR, Rizos A, Trenkwalder C, Rascol O, Pal S, Martino D, Carroll C, Paviour D, Falup-Pecurariu C & Kessel B 2015 'King's Parkinson's disease pain scale, the first scale for pain in PD: An international validation' Movement Disorders 30, (12) 1623-1631 , DOI PEARL
Kamel Boulos MN, Ifeachor E, Escudero Rodriguez J, Zhao P, Carroll CB, Costa P, Doppler G, Carrasco L, Spiru L & Helga K 2015 'LiveWell - Promoting Healthy Living and Wellbeing for Parkinson Patients Through Social Network and ICT Training: Lessons Learnt and Best Practices' International Journal of Healthcare Information Systems and Informatics
Cooke T, Carroll C, Zajicek J, Ellard S & Morrison K 2013 'Molecular genetic studies of neurodegenerative disease' J Neurol Neurosurg Psychiatry 84, (11) Author Site , DOI PEARL
Zeissler ML, Eastwood J, Oliver Hanemann C, Zajicek J & Carroll C 2013 'Δ9-TETRAHYDROCANNABINOL IS PROTECTIVE THROUGH PPARγ DEPENDENT MITOCHONDRIAL BIOGENESIS IN A CELL CULTURE MODEL OF PARKINSON'S DISEASE' J Neurol Neurosurg Psychiatry 84, (11) Author Site , DOI PEARL
Hilton D, Stephens M, Kirk L, Edwards P, Potter R, Zajicek J, Broughton E, Hagan H & Carroll C 2013 'Accumulation of α-synuclein in the bowel of patients in the pre-clinical phase of Parkinson’s disease' Acta Neuropathologica 1-7 Author Site , DOI
Carroll CB, Zeissler M-L, Hanemann CO & Zajicek JP 2012 'Δ⁹-tetrahydrocannabinol (Δ⁹-THC) exerts a direct neuroprotective effect in a human cell culture model of Parkinson's disease' Neuropathol Appl Neurobiol 38, (6) 535-547 Author Site , DOI
Ammoun S, Schmid MC, Ristic N, Zhou L, Hilton D, Ercolano E, Carroll C & Hanemann CO 2012 'The role of insulin-like growth factors signaling in merlin-deficient human schwannomas' Glia 60, (11) 1721-1733 Author Site , DOI PEARL
Carroll C, Palmer A, Cosby C & Zajicek J 2012 'Analysis and validation of a Parkinson's disease register as a recruitment tool for clinical studies' Clin Med (Lond) 12, (3) 210-215 Author Site , DOI PEARL
Carroll CB, Palmer A, Cosby C & Zajicek JP 2011 'Analysis and validation of a Parkinson's disease register as a recruitment tool for clinical studies' Trials 12 Suppl 1, , DOI
Carroll CB, Zeissler M-L, Chadborn N, Gibson K, Williams G, Zajicek JP, Morrison KE & Hanemann CO 2011 'Changes in iron-regulatory gene expression occur in human cell culture models of Parkinson's disease' Neurochem Int 59, (1) 73-80 Author Site , DOI PEARL
Carroll CB & Zajicek JP 2011 'Designing clinical trials in older people' Maturitas 68, (4) 337-341 Author Site , DOI PEARL
Carroll C, Krolikowski K, Mukonoweshuro W, Jones J & Hanemann CO 2010 'Unilateral cerebral hemisphere oedema as a peri-ictal phenomenon' J Neurol 257, (12) 2094-2096 Author Site , DOI
Carroll CB, Zeissler ML, Stone V, Hanemann CO & Zajicek JP 2010 'Cannabinoids Are Neuroprotective in a Human Cell Culture Model of Parkinson's Disease' MOVEMENT DISORDERS 25, S621-S621 Author Site PEARL
Carroll CB, Zeissler ML, Chadborn N, Gibson K, Williams GJ, Morrison KE, Zajicek JP & Hanemann CO 2010 'Changes in Iron-Regulatory Gene Expression Occur in Human Cell Culture Models of PD' MOVEMENT DISORDERS 25, S628-S628 Author Site PEARL
Zeissler, Carroll CB & Zajicek J 2010 'CBD & D9-THC - the two faces of cannabis' Cell Science 7, (1) PEARL
Sinclair AJ, Carroll C & Davies B 2009 'Cauda equina syndrome following a lumbar puncture' J Clin Neurosci 16, (5) 714-716 Author Site , DOI PEARL
Katzenschlager R, Schrag A, Evans A, Manson A, Carroll CB, Ottaviani D, Lees AJ & Hobart J 2007 'Quantifying the impact of dyskinesias in PD: the PDYS-26: a patient-based outcome measure' Neurology 69, (6) 555-563 Author Site , DOI
Carroll CB, Tengah DSNAP, Lawthom C & Venables G 2007 'The feminisation of British neurology: implications for workforce planning' Clin Med (Lond) 7, (4) 339-342 Author Site , DOI PEARL
Goodall EF, Greenway MJ, van Marion I, Carroll CB, Hardiman O & Morrison KE 2005 'Association of the H63D polymorphism in the hemochromatosis gene with sporadic ALS' Neurology 65, (6) 934-937 Author Site , DOI
Liu XG, Carroll CB, Wang SY, Zajicek J & Bain PG 2005 'Quantifying drug-induced dyskinesias in the arms using digitised spiral-drawing tasks' JOURNAL OF NEUROSCIENCE METHODS 144, (1) 47-52 Author Site , DOI PEARL
Carroll CB, Hilton DA, Hamon M & Zajicek JP 2005 'Muscle cramps and weakness secondary to graft versus host disease fasciitis' Eur J Neurol 12, (4) 320-322 Author Site , DOI PEARL
McSherry JW, Carroll CB, Zajicek J, Teare L & Bain P 2005 'Cannabis for dyskinesia in Parkinson disease: A randomized double-blind crossover study' Neurology 64, (6) 1100-1100 , DOI
Carroll CB, Bain PG, Teare L, Liu X, Joint C, Wroath C, Parkin SG, Fox P, Wright D & Hobart J 2004 'Cannabis for dyskinesia in Parkinson disease: a randomized double-blind crossover study' Neurology 63, (7) 1245-1250 Author Site , DOI
Carroll CB & Zajicek JP 2004 'The 'harlequin' sign in association with multiple sclerosis' JOURNAL OF NEUROLOGY 251, (9) 1145-1146 Author Site , DOI
Carroll CB & Bain PG 2004 'Do on-off variations cause discrepancies in the historical items of the UPDRS?' MOVEMENT DISORDERS 19, (5) 605-605 Author Site , DOI PEARL
Fox P, Bain PG, Glickman S, Carroll C & Zajicek J 2004 'The effect of cannabis on tremor in patients with multiple sclerosis' Neurology 62, (7) 1105-1109 Author Site , DOI
Carroll C, Hobart J, Fox C, Teare L & Gibson J 2004 'Stroke in Devon: knowledge was good, but action was poor' J Neurol Neurosurg Psychiatry 75, (4) 567-571 Author Site , DOI PEARL
Carroll C & Zajicek J 2004 'Provision of 24 hour acute neurology care by neurologists: manpower requirements in the UK' J Neurol Neurosurg Psychiatry 75, (3) 406-409 Author Site , DOI PEARL
Carroll CB & Gardner-Thorpe C 2004 'Charles Karsner Mills (1845-1931) and his syndrome' Some Aspects of History of Neuroscience 35-36
Hadjikoutis S, Carroll CB & Plant GTP 2004 'Raised intracranial pressure presenting with spontaneous periorbital bruising: two case reports' Journal of Neurology, Neurosurgery and Psychiatry 75, (8) PEARL
Weeks RA, Scaravilli F, Lees AJ, Carroll CB, Husain M & Rudge P 2003 'Cerebral amyloid angiopathy and motor neurone disease presenting with a progressive supranuclear palsy-like syndrome' Movement Disorders 18, (3)
Cooper AJ, Carroll CB & Mitchell IJ 1998 'Glutamate antagonists for Parkinson's disease - Rationale for use and therapeutic implications' CNS DRUGS 9, (6) 421-429 Author Site , DOI
Scott R 1998 'Neuropsychological, neurological and functional outcome following pallidotomy for Parkinson's disease. A consecutive series of eight simultaneous bilateral and twelve unilateral procedures' Brain 121, (4) 659-675 , DOI
Carroll CB, Scott R, Davies LE & Aziz T 1998 'The pallidotomy debate' British Journal of Neurosurgery 2, (12)
B. CARROLL C, SCOTT R, DAVIES LE & AZIZ T 1998 'The pallidotomy debate' British Journal of Neurosurgery 12, (2) 146-150 , DOI
Biousse V, Newman NJ, Carroll CB, Mewes K, Vitek JL, Bakay RAE, Baron MS & DeLong MR 1998 'Visual fields in patients with posterior GPi pallidotomy'
Mitchell IJ & Carroll CB 1997 'Reversal of parkinsonian symptoms in primates by antagonism of excitatory amino acid transmission: potential mechanisms of action' Neurosci Biobehav Rev 21, (4) 469-475 Author Site , DOI PEARL
MITCHELL IJ, HUGHES N, CARROLL CB & BROTCHIE JM 1995 'REVERSAL OF PARKINSONIAN SYMPTOMS BY INTRASTRIATAL AND SYSTEMIC MANIPULATIONS OF EXCITATORY AMINO-ACID AND DOPAMINE TRANSMISSION IN THE BILATERAL 6-OHDA LESIONED MARMOSET' BEHAVIOURAL PHARMACOLOGY 6, (5-6) 492-507 Author Site
CARROLL CB, HOLLOWAY V, BROTCHIE JM & MITCHELL IJ 1995 'NEUROCHEMICAL AND BEHAVIORAL INVESTIGATIONS OF THE NMDA RECEPTOR-ASSOCIATED GLYCINE SITE IN THE RAT STRIATUM - FUNCTIONAL IMPLICATIONS FOR TREATMENT OF PARKINSONIAN SYMPTOMS' PSYCHOPHARMACOLOGY 119, (1) 55-65 Author Site , DOI
Brotchie JM, Crossman ARC, Mitchell IJ, Duty S, Carroll CB, Cooper AJC, Henry B, Hughes N & Maneuf Y 1993 'Chemical signalling in the globus pallidus in parkinsonism' Progress in Brain Research (99) 125-139
Johns C 0 'Test title of article' Ethics and Behavior
Conference Papers
Cheesman A, Blackburn D, Carroll C, Cohen A, Coebergh J, Sokhi D, Wong SH & Woolmore J 2019 'ASSOCIATION OF BRITISH NEUROLOGISTS SUSTAINABILITY SPECIAL INTEREST GROUP (ABN SUSTAINABILITY SIG): FORMATION, OBJECTIVES AND INVITATION' 1-/-0/1900 1-/-0/1900 E9-E10 , DOI PEARL
Dominey T, Mullin S, Edwards E, Whipps J, Whipps S & Carroll C 2019 'USABILITY TESTING OF A NON-MOTOR SYMPTOM APP IN PD' 1-/-0/1900 1-/-0/1900 E47-E47 , DOI PEARL
Pujara P, Rideout J & Carroll C 2016 'IMPROVING PROVISION OF PARKINSON'S DISEASE EXERCISE CLASSES' 1-/-0/1900 1-/-0/1900 BMJ e1.14-e1 , DOI
Blight B, Davis J, Evans V, Hawkes N & Carroll C 2016 'IMPROVING THE EXPERIENCE OF DIAGNOSIS IN PARKINSON'S DISEASE' 1-/-0/1900 1-/-0/1900 BMJ e1.234-e1 , DOI
Dominey T, Newman C, Carroll C, Noad R, Appleyard B, Deeprose C & Hall S 2016 'PD-TAP: AN OBJECTIVE AND AUTOMATED MEASURE OF PARKINSON'S DISEASE SEVERITY' 1-/-0/1900 1-/-0/1900 BMJ e1.237-e1 , DOI
Carroll C, Wagner A, Watson P, Spoudeas H, Hawkins M, Walker D, Clare I, Holland T & Ring H 2016 'LONG-TERM COGNITIVE OUTCOME IN ADULT SURVIVORS OF AN EARLY CHILDHOOD POSTERIOR FOSSA BRAIN TUMOUR' 1-/-0/1900 1-/-0/1900 154-154
Stamford J, Isaacs T & Carroll C 2015 'People with Parkinson's design clinical trials charter to improve communication about, recruitment to and retention in Parkinson's clinical trials' 1-/-0/1900 1-/-0/1900 Springer Science and Business Media LLC , DOI
Creanor S, Vickery J, Eyre V, Zajicek J, Ball S, Elm J & Carroll C 2015 'Two-arm randomised futility trials: PD-stat - a futility trial of a potential neuroprotective treatment in people with Parkinson's disease' 1-/-0/1900 1-/-0/1900 Springer Science and Business Media LLC , DOI
Noad R, Newman C, Carroll C & Zajicek J 2015 'iPAD-BASED ASSESSMENT IN PARKINSON'S DISEASE' 1-/-0/1900 1-/-0/1900 BMJ e4.189-e4 , DOI
Koopman H, Jackson S, Anichtchik O & Carroll C 2015 'LPS INDUCES AGGREGATION OF α-SYNUCLEIN IN MONOCYTES' 1-/-0/1900 1-/-0/1900 BMJ e4.188-e4 , DOI
Jammeh E, Carroll C, Pearson S, Escudero J, Anastasiou A, Zajicek J & Ifeachor E 2015 'USING NHS PRIMARY CARE DATA TO IDENTIFY UNDIAGNOSED DEMENTIA' 1-/-0/1900 1-/-0/1900 BMJ e4.134-e4 , DOI
Hilton DA, Stephens M, Zajicek J, Broughton E, Hagan H, Edwards P & Carroll C 2013 'Accumulation of alpha synuclein in the bowel in preclinical Parkinson's disease' 1-/-0/1900 1-/-0/1900 11-11
Hilton DA, Zeissler ML, Zhang H, Zajicek J, Hicks J, Eastwood J & Carroll C 2013 'Cannabinoid receptor expression in Parkinson's disease' 1-/-0/1900 1-/-0/1900 34-35
Salter E, Zeissler ML, Alexander SPH, Hanemann CO, Zajicek JP & Carroll CB 2012 'ENDOCANNABINOID TOXICITY IN A CELL CULTURE MODEL OF PARKINSON'S DISEASE' 1-/-0/1900 1-/-0/1900 BMJ A13.4-A14 , DOI
Zeissler M, Hanemann CO, Zajicek JP & Carroll CB 2012 'FAAH INHIBITION IS PROTECTIVE IN A CELL CULTURE MODEL OF PARKINSON'S DISEASE' 1-/-0/1900 1-/-0/1900 , DOI
Zeissler M, Carroll CB, Hanemann CO & Zajieck JP 2012 '108 Investigating the neuroprotective properties of Δ9-THC in a cell culture model of Parkinson's disease' 1-/-0/1900 1-/-0/1900 BMJ e1.58-e1 , DOI
Carroll C, Zajicek JP, Hanemann CO, Stone V & Zeissler M 2010 'CANNABINOIDS ARE NEUROPROTECTIVE IN A HUMAN CELL CULTURE MODEL OF PARKINSON'S DISEASE' 1-/-0/1900 1-/-0/1900 E60-E60 , DOI
Carroll C, Williams GJ, Chadborn NH, Hanemann CO, Zajicek JP, Morrison KE, Gibson K & Zeissler M 2010 'CHANGES IN IRON-REGULATORY GENE EXPRESSION OCCUR IN HUMAN CELL CULTURE MODELS OF PARKINSON'S DISEASE' 1-/-0/1900 1-/-0/1900 E29-E29 , DOI
Carroll CB, Chadborn N, Hanemann O & Zajicek J 2009 'CANNABINOIDS ARE NEUROPROTECTIVE IN A CELL CULTURE MODEL OF PARKINSON'S DISEASE' 1-/-0/1900 1-/-0/1900 , DOI
Sinclair AJ, Carroll C & Davies MB 2007 'A rare complication of a common procedure: Acute cauda equina syndrome following a lumbar puncture' 1-/-0/1900 1-/-0/1900 218-218
Carroll CB, Majumdar D, Winer JB & Davies NP 2005 'Childhood onset demyelinating neuropathy and cataracts: A potentially treatable disorder' 1-/-0/1900 1-/-0/1900 1323-1324
Carroll CB & Zajicek JP 2005 'Clinical viral encephalitis in adults: A 10 year retrospective study' 1-/-0/1900 1-/-0/1900 157-158
Carroll CB & Zajicek JZ 2003 'Meeting the Association of British Neurologists guidelines: Provision of 24 hour acute neurology care by neurologists' 1-/-0/1900 1-/-0/1900 1453-1453
Carroll C, Hobart J, Fox C, Teare L & Gibson J 2003 'Stroke in Devon: The need to translate knowledge into action' 1-/-0/1900 1-/-0/1900 1176-1177
Carroll C & Gardner-Thorpe C 2003 'Charles Karsner Mills (1845-1931) and his syndrome' 1-/-0/1900 1-/-0/1900 406-406
Posters
Thomas C, Mohammed B, Abdelgadir E, Silverdale MA, Kobylecki C, Osborne L, Smith M, Hulejczuk A, Saha AR & Bain PG Thomas C, Mohammed B, Abdelgadir E, Silverdale MA, Kobylecki C, Osborne L, Smith M, Hulejczuk A, Saha AR & Bain PG 0 'Can implementation of technology transform the management of Parkinson's? Lessons learnt from the Parkinson's KinetiGraph (TM) (PKG (TM)) service evaluation project' 01/01/1900 01/01/1900 Author Site PEARL
Chloe TLY, Dominey T, Pearson E, Murphy F & Carroll C Chloe TLY, Dominey T, Pearson E, Murphy F & Carroll C 0 'Designing a care pathway for high risk parkinson’s patients' 01/01/1900 01/01/1900 , DOI PEARL
Hutchinson L, Dominey T, Pearson E, Murphy F, Bell L & Carroll C Hutchinson L, Dominey T, Pearson E, Murphy F, Bell L & Carroll C 0 'Evaluating the clinical utility of the parkinson’s kinetigraph (PKG)' 01/01/1900 01/01/1900 , DOI PEARL
Palin M, Rideout J, Carroll C & Evans V Palin M, Rideout J, Carroll C & Evans V 0 'Improving community exercise provision in Parkinson’s' 01/01/1900 01/01/1900 , DOI PEARL
Abdelgadir E, Patel D, O’Gara M, Leach O, Masri OA, Bhattacharjee S, Shah A, Talbot J, Zafar H & Carroll C Abdelgadir E, Patel D, O’Gara M, Leach O, Masri OA, Bhattacharjee S, Shah A, Talbot J, Zafar H & Carroll C 0 'PO001 Successful neurology trainee research network collaborative audit' 01/01/1900 01/01/1900 , DOI PEARL
Robinson A, Pearson E, Murphy F, Davis J & Carroll C Robinson A, Pearson E, Murphy F, Davis J & Carroll C 0 'PO077 Evaluating a nurse-led diagnosis pathway in parkinson’s disease' 01/01/1900 01/01/1900 , DOI PEARL
Abdelgadir E, Patel D, O’Gara M, Leach O, Masri OA, Bhattacharjee S, Shah A, Talbot J, Zafar H & Carroll C Abdelgadir E, Patel D, O’Gara M, Leach O, Masri OA, Bhattacharjee S, Shah A, Talbot J, Zafar H & Carroll C 0 'PO213 Sonar identifies research training needs in a clinical training program' 01/01/1900 01/01/1900 , DOI PEARL
Shaw N, Evans V, Rideout J & Carroll C Shaw N, Evans V, Rideout J & Carroll C 0 'PO219 Guidelines for pd patient involvement in service development' 01/01/1900 01/01/1900 , DOI PEARL
Abdelgadir E, Almasri O, Bhattacharjee S, Leach O, O'gara M, Patel D, Shah A, Talbot J, Zafar H & Carroll C Abdelgadir E, Almasri O, Bhattacharjee S, Leach O, O'gara M, Patel D, Shah A, Talbot J, Zafar H & Carroll C 0 'SONAR identifies registrar research training needs in a clinical training program' 01/01/1900 01/01/1900 Author Site
Abdelgadir E, Almasri O, Bhattacharjee S, Patel D, O'gara M, Leach O, Shah A, Talbot J, Zafar H & Carroll C Abdelgadir E, Almasri O, Bhattacharjee S, Patel D, O'gara M, Leach O, Shah A, Talbot J, Zafar H & Carroll C 0 'Successful neurology trainee research network collaborative audit' 01/01/1900 01/01/1900 Author Site

Links

http://www.neurocore.org.uk/